J
John-Kenyon American Eye Institute | New Albany, IN
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
-Ranibizumab
KPI-121
Bevacizumab
Ranibizumab
AGN-195263
Lifitegrast
Triamcinolone Acetonide
Difluprednate
Ranibizumab+Deferred
Pemafibrate
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 18 total trials
Locations recently updated
ABBV-RGX-314 (also known as RGX-314 and surabgene lomparvovec (sura-vec)) is being developed as a novel one-time gene therapy for the treatment of ne...
Enrolling
Wet Age-related Macular Degeneration
WetAMD
Genetic: ABBV-RGX-314 Dose 1
Biological: Aflibercept (EYLEA®)
Trial sponsors
K
S
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems